company background image
CHE logo

Chemed NYSE:CHE Stock Report

Last Price

US$599.04

Market Cap

US$9.0b

7D

2.9%

1Y

15.3%

Updated

27 Sep, 2024

Data

Company Financials +

CHE Stock Overview

Provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States.

CHE fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance6/6
Financial Health6/6
Dividends0/6

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

US$685.00
FV
12.5% undervalued intrinsic discount
7.20%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
19 days agoauthor updated this narrative

Chemed Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Chemed
Historical stock prices
Current Share PriceUS$599.04
52 Week HighUS$654.62
52 Week LowUS$497.37
Beta0.44
11 Month Change4.68%
3 Month Change10.41%
1 Year Change15.27%
33 Year Change30.85%
5 Year Change45.23%
Change since IPO5,195.38%

Recent News & Updates

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Aug 26
Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed Remains A Buy On Long-Term Economics

Aug 16

Recent updates

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Aug 26
Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed Remains A Buy On Long-Term Economics

Aug 16

Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Jul 19
Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Chemed: Growth Does Not Justify The Current Stock Price

May 20

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

May 14
Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Apr 26
Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Mar 01
Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

The Price Is Right For Chemed Corporation (NYSE:CHE)

Dec 30
The Price Is Right For Chemed Corporation (NYSE:CHE)

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Nov 30

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Oct 26
Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed - Showcasing Why It's So Reliable

Aug 26

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

Aug 13

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Aug 01
Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Jul 14
Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Jun 07
Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Apr 09
Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed Q4 2022 Earnings Preview

Feb 22

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Feb 14

Is Chemed (NYSE:CHE) Using Too Much Debt?

Jan 05
Is Chemed (NYSE:CHE) Using Too Much Debt?

Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Dec 17
Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Chemed declares $0.38 dividend

Nov 04

Chemed Q3 2022 Earnings Preview

Oct 28

Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Oct 01
Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

Sep 16
Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

Buy Chemed To Reduce Equity Beta And Stabilize Portfolio Returns

Aug 26

A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

Aug 16
A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

Shareholder Returns

CHEUS HealthcareUS Market
7D2.9%-1.1%0.6%
1Y15.3%9.7%32.1%

Return vs Industry: CHE exceeded the US Healthcare industry which returned 9.7% over the past year.

Return vs Market: CHE underperformed the US Market which returned 32.1% over the past year.

Price Volatility

Is CHE's price volatile compared to industry and market?
CHE volatility
CHE Average Weekly Movement2.5%
Healthcare Industry Average Movement6.8%
Market Average Movement6.4%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: CHE has not had significant price volatility in the past 3 months.

Volatility Over Time: CHE's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
197015,087Kevin McNamarawww.chemed.com

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Chemed Corporation Fundamentals Summary

How do Chemed's earnings and revenue compare to its market cap?
CHE fundamental statistics
Market capUS$9.00b
Earnings (TTM)US$300.92m
Revenue (TTM)US$2.34b

29.9x

P/E Ratio

3.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CHE income statement (TTM)
RevenueUS$2.34b
Cost of RevenueUS$1.50b
Gross ProfitUS$839.98m
Other ExpensesUS$539.06m
EarningsUS$300.92m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Oct 29, 2024

Earnings per share (EPS)20.07
Gross Margin35.96%
Net Profit Margin12.88%
Debt/Equity Ratio0%

How did CHE perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

8%

Payout Ratio